SYNTHOS RESEARCH

Coherent COHR

Technology · Hardware, Equipment & Parts · Synthos Deep Dive · 2026-07-03

$333.36
Hold
Risk 7Growth 7Exponential 6Fair value $375 $200–$500

At a glance

VerdictHold — systematic Synthos tier
Price (2026-07-02)$333.36 · market cap ~$52.9B (down −9.6% on the print day)
Synthos scores (0–10)Downside Risk 7 · Growth Quality 7 · Exponential Potential 6
Synthos fair value (base case)~$375+13% · full range $200 (bear) – $500 (bull)
Street consensus$333 (high $455 / low $230; 24 Buy · 6 Hold · 0 Sell) — context, not our anchor
Valuation145× GAAP trailing EPS · 61× FY26E · 40× FY27E · 27× FY28E (non-GAAP) · EV/S 8.3× TTM · EV/EBITDA 47× TTM
Exponential Potential6/10 · Moderate-High — ~30% forward revenue CAGR and accelerating; huge AI-datacenter optics TAM; but beta 2.05 makes it a volatile cyclical, not a clean compounder
TechnicalsUptrend but toppy — $333, −22% off 52-wk high, above 200-DMA / below 50-DMA, RSI 45, +285% 12-mo (SPY +21%)
ConvictionLow — 1 KB voice (management, half-weighted), 4 traceable claims, net conviction 0. Fundamentals/quant driven.
Position sizingSatellite / tactical, ~1–2% — a cyclical AI-optics bet, sized small
Next catalyst2026-08-12 Q4 FY26 earnings (Street EPS $1.62, rev ~$1.98B)
Single biggest riskDemand is concentrated in one hot cycle (AI datacenter transceivers) — a capex pause or share loss to Chinese/peer optics de-rates a 40×-forward stock hard

One-line thesis. Coherent is a merger-built photonics leader (II-VI + the old Coherent) that has become a front-line AI-datacenter optics supplier — revenue is re-accelerating (Q3 FY26 +21% Y/Y, non-GAAP operating margin 20.3%) and estimates imply ~30% forward revenue growth, but you are paying 61× this-year non-GAAP EPS for a beta-2, cyclical name whose story rests almost entirely on the AI capex wave continuing. Buy tactically and small; this is not a core compounder.

◆ Synthos call — Hold COHR is a solid business largely reflected at ~$375 — fine to keep, no reason to chase; it gets interesting again below ~$319.
Downside Risk (lower = safer)
7/10 · High
Beta 2.05, 61× FY26E non-GAAP EPS, net-debt/EBITDA 1.6×, and demand tied to one hot cycle (AI datacenter).
Growth Quality
7/10 · High
~30% forward revenue CAGR and margins inflecting up, but ROIC ~4% and GAAP earnings still thin under merger amortization.
Exponential Potential
6/10 · High
Growth is *accelerating* (positive 2nd derivative) into a huge AI-optics TAM with a $53B cap — but beta-2 cyclicality, not a clean compounder.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

In plain English

Coherent makes lasers and optical parts — including the tiny high-speed optical transceivers that shuffle data between chips inside AI data centers. That last business is booming because everyone is building AI computers, and Coherent's sales and profits are climbing fast again after a rough patch following a big 2022 merger.

The catch: the stock is expensive and jumpy. It has more than tripled in a year, and it fell almost 10% in a single day on its last earnings report even though the numbers were good — that tells you how much good news is already priced in. It also swings about twice as hard as the market (a "beta" of 2). So this is a higher-risk, higher-reward stock, not a sleep-at-night holding.

Our verdict is Buy — Tactical: worth owning in a small amount as a bet on the AI build-out, but sized like a satellite, not a core position.

Here's what our three scores mean in everyday terms:

The one big worry: almost all the excitement depends on AI data-center spending staying hot. If big customers pause, or cheaper rivals (including Chinese suppliers) take share, an expensive stock like this can fall a long way.


Price & moving averages 12 months · 50 & 200-day averages · 52-week range

49150252353455Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2652w hi $42750-DMA 369Price 333200-DMA 23752w lo $87

Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

46151255359464Jul '25Sep '25Nov '25Feb '26Apr '26Jul '2620-day avg 385Price 333

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

705030Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26RSI 41.2

Above 70 (red band) = overbought, below 30 (green band) = oversold. Currently 41.

MACD 12 / 26 / 9 · trend & momentum

0Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26signal 6.7MACD 0.4

Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago

67179291402514Jul '25Sep '25Nov '25Feb '26Apr '26Jul '26COHR 377XLK (sector) 142S&P 500 120

Solid = COHR · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

06111723$2BFY22EPS $5$5BFY23EPS $-3$5BFY24EPS $-1$6BFY25EPS $3$7BFY26EEPS $5$10BFY27EEPS $8$13BFY28EEPS $12$20BFY29EEPS $0

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$333.36
Market cap$53B
P/E trailing15×
P/E FY26E / FY27E61× / 40×
EV / Sales8.3×
EV / EBITDA47.1×
Gross margin37.0%
Net margin7.1%
Dividend yield0.00%
Beta2.054
52-wk range$87 – $427
RSI(14)45
50 / 200-DMA$369 / $237
12-mo return+285% (SPY +21%)
Street target$333 ($230–$455)
Analyst grades23 Buy · 6 Hold · 0 Sell
FMP ratingB-
Next earnings2026-08-05

What the experts actually said 4 traceable claims on COHR · showing the highest-conviction voices

“As AI datacenter infrastructure scales, Coherent is rapidly expanding capacity and is well positioned to capitalize on a multi-year growth opportunity.”
Cohr Mgmtmanagementconviction 802026-05-06COHR-earnings-2026Q2:685180ba01
“For fiscal 2026, the company projects a non-GAAP normalized tax rate of 19%, applied to each quarter of the fiscal year.”
Cohr Mgmtmanagementconviction 602026-05-06COHR-earnings-2026Q2:3399633b9c

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

1. What it is

Coherent Corp. (NYSE: COHR) is a global photonics company headquartered in Saxonburg, Pennsylvania. Today's company is the product of the 2022 combination in which II-VI Incorporated acquired the legacy Coherent, Inc. and adopted the Coherent name — so the business is far broader than the old laser maker: it spans optical communications (datacenter transceivers, telecom), industrial and semiconductor-capital lasers, compound-semiconductor materials (silicon carbide, indium phosphide, gallium arsenide), and aerospace/defense optics. CEO is Jim Anderson (ex-Lattice Semiconductor). Fiscal year ends June 30.

(Note: the FMP "profile" description is stale — it still reads as pre-merger "Coherent, Inc." The earnings release, CEO, and segment data confirm the real entity is the merged Coherent Corp. / photonics leader.)

Revenue mix (FMP segmentation — note it does not sum to total revenue; FMP tags only two sub-segments):

2. The expert thesis — why the (thin) panel reads as it does (traceable)

Honesty first: there is no independent expert coverage of COHR in the Synthos knowledge base. total_claims = 4, and every claim traces to management itself (COHR_mgmt), which we half-weight by design because they talk their own book. There are zero outside net-bullish thinkers. So this verdict is explicitly fundamentals- and quant-driven, not conviction-driven — unlike a high-breadth name where a dozen independent voices corroborate.

What the (management) claims say, traceably:

Composite read. With breadth 1 and net conviction 0, the KB neither confirms nor refutes the bull case — it is simply thin. Everything load-bearing below comes from the reported financials, the analyst estimate set, and the earnings-release guidance, all labeled as such.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics:

Score0–10The read
Downside Risk (lower = safer)7 · HighBeta 2.05, 61× FY26E non-GAAP EPS (145× GAAP TTM), EV/EBITDA 47× TTM, net-debt/EBITDA 1.58×, and demand concentrated in one hot capex cycle. Fell −9.6% on a good print — the bar is high.
Growth Quality7 · Good~30% forward revenue CAGR (FY25→FY28E) with non-GAAP operating margin up to 20.3% and gross margin expanding — but ROIC ~4%, ROE ~5%, and heavy merger goodwill/intangibles (42% of assets) keep GAAP earnings thin.
Exponential Potential6 · Moderate-HighGrowth is accelerating (revenue +21% Y/Y and rising; EPS inflecting) into a large AI-optics TAM, and a $53B cap still has room. Docked from higher only by beta-2 cyclicality — this is a volatile cyclical, not a clean secular compounder.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities; the cases bound the range.

CaseKey assumptionsFair value
BullAI-datacenter optics demand stays torrid; Coherent holds transceiver share and margins keep climbing. FY27E non-GAAP EPS beats to ~$9.5 (vs $8.29 cons); market keeps a premium ~52× on the acceleration.~$500 (+50%)
Base (our anchor)Estimates roughly hit — FY27E non-GAAP EPS ~$8.29; a high-growth but cyclical AI-optics supplier earns a ~45× multiple.~$375 (+13%)
BearAI capex digests / a hyperscaler pauses, or Chinese/peer optics take share; growth halves and the multiple de-rates. FY27E EPS misses to ~$6.5; multiple compresses to ~30×.~$200 (−40%)

Synthos fair value = the base case, ~$375 (+13%), with the full $200–$500 span as the honest range. This anchor sits just above the Street's $333 consensus (which is essentially at the current price) and our bear is between the Street's $230 low and worse. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). COHR is an accelerating cyclical, which is the interesting middle:

Exponential Potential: Moderate-High. Own it for accelerating AI-optics exposure, sized for the volatility — not as a set-and-forget compounder.

5. Financials (real numbers — FMP annual/quarterly + earnings release)

6. Valuation — priced in or room?

COHR is not cheap on any trailing measure (145× GAAP EPS, 47× EV/EBITDA TTM, 8.3× EV/sales). The bull's defense is the same as any inflecting name: EPS is growing fast enough that the forward multiple compresses. On live consensus the non-GAAP forward P/E is 61× (FY26E) → 40× (FY27E) → 27× (FY28E), and forward EV/EBITDA falls from ~44× (FY26E) to ~32× (FY27E). So even at a flat price, the multiple normalizes toward the low-30s/high-20s if the estimates hit — a big "if" for a cyclical.

A reverse read: at $333 the market is paying roughly the analysts' ~30% revenue CAGR and margin lift in full. There is little valuation cushion — this is a momentum/execution valuation, not a value one. Street targets (context): consensus $333 (right at the price), high $455, low $230, median $330; FMP letter rating B− (price-to-earnings score 1/5 — i.e. flagged expensive). Our $375 base FV is modestly above consensus because we give some credit to the acceleration, but we hold a wide bear precisely because the multiple leaves no room for a stumble.

7. Technicals (from the FMP tech block)

8. Moat & competitive position

Coherent's edge is scale + vertical integration in photonics: it makes not just the optical transceivers but the underlying compound-semiconductor materials (InP, GaAs, SiC) and lasers, which is hard to replicate and matters as datacenter optics move to higher speeds (800G/1.6T). Manufacturing scale and a broad IP portfolio are genuine barriers. But the moat is narrower than a software or drug moat: optics is competitive, partly commoditizing, and faces low-cost Chinese transceiver suppliers plus well-capitalized peers. Demand is also customer-concentrated among a handful of hyperscalers/networking OEMs — a structural risk.

Peer set (FMP-tagged, market cap): Fabrinet (FN) $17.9B — the closest optics-manufacturing comp; Flex (FLEX) $50.1B; Jabil (JBL) $35.8B; GlobalFoundries (GFS) $38.3B; Teledyne (TDY) $30.2B; Fortive (FTV) $19.1B; Trimble (TRMB) $12.4B; plus AST SpaceMobile, EchoStar, SS&C (looser comps). Against FN — the purest peer — COHR is larger, more vertically integrated, and carrying more leverage and merger intangibles. (Note: the truest competitive frame, pure-play datacenter optics like Lumentum/InnoLight, is not in the FMP peer list.)

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): a hyperscaler capex pause or two consecutive quarters of decelerating datacenter revenue; non-GAAP gross margin rolling back below ~37%; a guidance cut; or the forward multiple staying >45× while growth slows (no margin of safety left).

11. Key risks

12. Verdict, position sizing & monitoring

Buy — Tactical. COHR is a genuine, accelerating AI-datacenter optics story — Q3 FY26 revenue +21% Y/Y, non-GAAP operating margin 20.3% and rising, ~30% forward revenue CAGR on consensus, and management guiding Q4 higher. That earns a constructive stance. But it is a high-beta (2.05), richly valued (61× FY26E non-GAAP), cyclical name with no independent expert corroboration in the KB and a demand base tied to one capex wave — which caps both the conviction and the position size. This is a satellite bet on the AI build-out, not a core holding.


Provenance & disclosures